XML 30 R19.htm IDEA: XBRL DOCUMENT v3.22.1
Significant Customers and Contingencies
12 Months Ended
Dec. 31, 2021
Risks and Uncertainties [Abstract]  
Significant Customers and Contingencies

 

(12) Significant Customers and Contingencies

 

We had five significant customers for the year ended December 31, 2021.

 

      For the years ended
December 31,
 
Customer #  Product Category  2021   2020 
1  Personal Care Ingredients   26%   30%
2  Solésence®   19%   14%
3  Solésence®   15%   11%
4  Solésence®   10%   5%
5  Advanced Materials (Medical Diagnostics customer)   8%   20%
   Total   78%   80%


 

 Accounts receivable balances for these five customers were approximately:

 

     

For the years ended

December 31,

 
Customer #  Product Category  2021   2020 
1  Personal Care Ingredients  $641   $381 
2  Solésence®   534    342 
3  Solésence®   1,048    116 
4  Solésence®   239    863 
5  Advanced Materials (Medical Diagnostics customer)   -0-    735 
   Total  $2,462   $2,437 

 

We currently have exclusive supply agreements with BASF Corporation (“BASF”), our largest customer, that have contingencies outlined which could potentially result in the license of technology and/or the sale of production equipment from the Company to the customer intended to provide capacity sufficient to meet the customer’s production needs. This outcome may occur if we fail to meet certain performance requirements. Our supply agreements with BASF also “trigger” a technology transfer right in the event of our insolvency, as further defined within the agreements. In the event of an equipment sale, upon incurring a triggering event, the equipment would be sold to the customer at either 115% of the equipment’s net book value or the greater of 30% of the original book value of such equipment, and any associated upgrades to it, or 115% of the equipment’s net book value, depending on the equipment and related products.

 

If a triggering event were to occur and BASF elected to proceed with the license and related equipment sale mentioned above, we would receive royalty payments from this customer for products sold using our technology; however, we would lose both significant revenue and the ability to generate significant revenue to replace that which was lost in the near term. Replacement of necessary equipment that could be purchased and removed by the customer pursuant to this triggering event could take in excess of twelve months. Any additional capital outlays required to rebuild capacity would probably be greater than the proceeds from the purchase of the assets as dictated by our agreement with the customer. Similar consequences would occur if we were determined to have materially breached certain other provisions of the supply agreement with BASF. Any such event would also likely result in the loss of many of our key staff and line employees due to economic realities. We believe that our employees are a critical component of our success, and it could be difficult to replace them quickly. Given the occurrence of any such event, we might not be able to hire and retain skilled employees given the stigma relating to such an event and its impact on us.